tiprankstipranks
Sonim Technologies Inc (SONM)
NASDAQ:SONM
Want to see SONM full AI Analyst Report?

Sonim Technologies (SONM) AI Stock Analysis

372 Followers

Top Page

SONM

Sonim Technologies

(NASDAQ:SONM)

Select Model
Select Model
Select Model
Underperform 40 (OpenAI - Gpt-5.6Sol)
Rating:40Underperform
Price Target:
$3.00
▼(-4.76% Downside)
Action:Downgraded
Date:08/20/26
Overall score is held down primarily by weak financial performance (ongoing losses, heavy cash burn, and negative equity). Technicals also reflect a sustained downtrend (below major moving averages with negative MACD). Corporate events are mixed but net risk-tilted due to delisting pressure and reduced financing flexibility, partially offset by the preferred financing.
Positive Factors
Rugged enterprise mobility niche
Sonim targets demanding work environments where durability, push-to-talk and workforce management are important. This focused positioning can support customer retention and differentiation versus general-purpose handset providers.
Negative Factors
Persistent unprofitability
Sonim has not translated revenue into sustainable operating earnings, and historical results have been volatile. Continued losses constrain internal investment, increase financing dependence and make the business model less resilient.
Read all positive and negative factors
Positive Factors
Negative Factors
Rugged enterprise mobility niche
Sonim targets demanding work environments where durability, push-to-talk and workforce management are important. This focused positioning can support customer retention and differentiation versus general-purpose handset providers.
Read all positive factors

Sonim Technologies (SONM) vs. SPDR S&P 500 ETF (SPY)

Sonim Technologies Business Overview & Revenue Model

Company Description
DNA X, Inc., formerly known as Sonim Technologies, Inc. until its rebranding in January 2026, is a company established in 1999 and headquartered in San Diego, California. The firm specializes in delivering enterprise-grade 5G solutions across a br...
How the Company Makes Money
null...

Sonim Technologies Financial Statement Overview

Summary
Financial quality is weak: the company remains loss-making (net loss and negative operating profit) with persistent, deep cash burn (TTM operating cash flow and free cash flow materially negative). The balance sheet is pressured by negative stockholders’ equity, reducing flexibility despite modest absolute debt.
Income Statement
18
Very Negative
Balance Sheet
24
Negative
Cash Flow
12
Very Negative
BreakdownTTMMar 2026Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue-27.91M0.0058.30M93.63M69.83M54.57M
Gross Profit-13.50M-4.30M9.92M19.32M11.62M6.41M
EBITDA-2.65M-2.17M-29.84M2.50M-11.43M-36.33M
Net Income-8.55M-20.66M-33.65M-90.00K-14.09M-38.63M
Balance Sheet
Total Assets4.52M43.90M39.74M56.04M53.69M41.09M
Cash, Cash Equivalents and Short-Term Investments900.00K1.30M5.34M9.40M13.21M11.23M
Total Debt2.40M5.07M0.0055.00K213.00K214.00K
Total Liabilities5.75M50.63M45.44M33.67M33.64M22.46M
Stockholders Equity-1.23M-6.73M-5.70M22.37M20.05M18.63M
Cash Flow
Free Cash Flow-14.60M-23.53M-8.70M-4.09M-12.37M-38.52M
Operating Cash Flow-14.51M-23.53M-8.49M-4.05M-12.36M-38.48M
Investing Cash Flow3.26M0.00-214.00K-36.00K-8.00K-46.00K
Financing Cash Flow10.13M19.49M4.65M272.00K14.35M27.61M

Sonim Technologies Technical Analysis

Technical Analysis Sentiment
Negative
Last Price3.15
Price Trends
50DMA
4.02
Negative
100DMA
4.13
Negative
200DMA
4.95
Negative
Market Momentum
MACD
-0.13
Negative
RSI
43.78
Neutral
STOCH
4.12
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SONM, the sentiment is Negative. The current price of 3.15 is below the 20-day moving average (MA) of 3.47, below the 50-day MA of 4.02, and below the 200-day MA of 4.95, indicating a bearish trend. The MACD of -0.13 indicates Negative momentum. The RSI at 43.78 is Neutral, neither overbought nor oversold. The STOCH value of 4.12 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SONM.

Sonim Technologies Risk Analysis

Sonim Technologies disclosed 43 risk factors in its most recent earnings report. Sonim Technologies reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Sonim Technologies Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$40.43M9.1451.72%28925.73%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
51
Neutral
$73.47M-1.96-349.07%28.74%-79419.35%
49
Neutral
$22.69M-1.61-20.20%-21.23%-52.50%
40
Underperform
$4.94M-0.15668.17%4.17%-238.36%
39
Underperform
$1.27M-0.01-204.44%-22.15%71.74%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SONM
Sonim Technologies
3.38
-6.16
-64.57%
UTSI
UTStarcom
2.41
-0.01
-0.62%
FIEE
FiEE
4.66
1.79
62.37%
ASNS
Actelis Networks, Inc.
0.04
-4.66
-99.09%
MOB
Mobilicom
6.29
2.30
57.64%

Sonim Technologies Corporate Events

Business Operations and StrategyPrivate Placements and FinancingRegulatory Filings and Compliance
Sonim Technologies Strengthens Capital Structure With Preferred Financing
Positive
Jul 2, 2026
On June 29, 2026, DNA X, Inc. agreed to sell 1,346,531 shares of non-voting Series B Convertible Preferred Stock to major shareholder DNA Holdings Venture, Inc. in a private placement, raising $8.1 million through $5 million in cash and cancellati...
Business Operations and StrategyPrivate Placements and Financing
Sonim Technologies Ends Major Equity Purchase Agreement
Negative
Jun 4, 2026
DNA X, Inc. previously entered into a ChEF Purchase Agreement with Chardan Capital Markets LLC on September 29, 2025, under which Chardan committed, subject to conditions, to purchase up to $500 million of the company’s common stock and rece...
Delistings and Listing ChangesPrivate Placements and FinancingRegulatory Filings and Compliance
Sonim Technologies Faces Nasdaq Delisting After New Financing
Negative
May 27, 2026
On May 20, 2026, DNA X, Inc. entered into a securities purchase agreement with DNA Holdings Venture, Inc., and on May 26, 2026, it issued a $3.05 million secured convertible note, funded by $1.8 million in cash and the exchange of a prior note plu...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 20, 2026